Double-shelled, rattle-architecture covalent organic framework: harnessing morphological manipulation for enhanced synergistic multi-drug chemo-photothermal cancer therapy

• Published in: Journal of materials chemistry. B, Materials for biology and medicine Materials for biology and medicine, 2024-08, Vol.12 (32), p.7915-7933
• Main Authors: Rahmani Khalili, Nafiseh, Badiei, Alireza, Pirkani, Zanyar, Mohammadi Ziarani, Ghodsi, Vojoudi, Hossein, Golmohamadi, Amir, Varma, Rajender S
• Format: Article
• Language: English
• Subjects: Biocompatibility; Biomedical materials; Cancer; Cancer therapies; Doxorubicin; Folic acid; Gold; Hydrophobicity; In vivo methods and tests; Morphology; Nanoparticles; Photothermal conversion; Physical characteristics; Polyethylene glycol; Therapeutic applications
• ISSN: 2050-750X; 2050-7518; 2050-7518
• DOI: 10.1039/d4tb01096e

Morphological modulation in covalent organic frameworks (COFs) with particular emphasis on the correlation between structure and target applications in biomedical fields, is currently in its early stage of evolution. Herein, a multifunctional rattle-architecture imine-based COF with a mobile core of gold nanoparticles (Au NPs) and an outer polydopamine (PDA) shell, tailored for cancer treatment, has been developed to effectively integrate dual responsive release capabilities with the potential for multiple therapeutic applications. The engineered COF displays outstanding crystallinity, a suitable size and precisely controlled morphological characteristics. By leveraging COF and PDA attributes, the successful co-delivery of hydrophilic doxorubicin (DOX) and hydrophobic docetaxel (DTX) within discrete compartments is achieved responsive to both pH and near-infrared triggers. Designed nanocarrier outperforms prior COFs with a superior 83.7% DOX loading capacity, thanks to its expansive internal space and porous shell. Taking advantage of the inclusion of Au core and the concurrent presence of COF and PDA outer shells, the nanocarrier exhibits a significant photothermal-conversion capability. The rattle-architecture double-shelled Au@RCOF@PDA were functionalized with poly(ethylene glycol)-folic acid (PEG-FA) to confer the system with active-targeting capability and enhanced biocompatibility. Through in vitro and in vivo evaluations, the designed system demonstrates an exceptional synergistic anti-tumor effect, along with favorable biosafety and histocompatibility. This study not only sheds light on the remarkable merits offered by regulating the morphology of COF-based systems in cancer therapy but also highlights the potential for synergistic therapeutic approaches in advancing cancer treatment strategies. DOX/DTX-loaded RCOF@PDA-PEG-FA for concurrent in vivo dual drug therapy along with photothermal cancer therapy.